Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista Facultad Nacional de Salud Pública
Print version ISSN 0120-386XOn-line version ISSN 2256-3334
Abstract
CARDONA-ARIAS, Jaiberth Antonio and ORREGO-MARIN, Claudia Patricia. Meta-analysis of the diagnostic validity of Human Immunodeficiency Virus screening tests in blood banks, 2000-2020. Rev. Fac. Nac. Salud Pública [online]. 2022, vol.40, n.3, e04. Epub May 31, 2023. ISSN 0120-386X. https://doi.org/10.17533/udea.rfnsp.e347170.
Objective:
To evaluate the diagnostic validity of the enzyme-linked immunosorbent assay (ELISA) for human immunodeficiency virus (HIV) in blood banks, based on studies published between 2000 and 2020.
Methodology:
We performed a systematic review and meta-analysis of diagnostic tests, using a random-effects model for the sensitivity, specificity, positive and negative likelihood ratio, diagnostic odds ratio (DOR), and ROC curve, with 95% confidence intervals. Heterogeneity was assessed with the DerSimonianLaird Q(χ2) statistic and the I2 inconsistency statistic. Uncertainty was assessed using percentage study weights.
Results:
15 studies were included. The third-generation ELISA (antibody detection) was applied for 2,992 infected and 4,076 healthy individuals, and the fourth-generation ELISA (simultaneous antigen-antibody detection) was used for 967 infected and 154,264 healthy individuals. Both showed close to 100% sensitivity, but there was an improved specificity in the fourth-generation assays (98% vs. 100%). Both technologies’ likelihood ratios, DOR, and ROC curve aptly distinguished between healthy and infected individuals.
Conclusion:
The third and fourth-generation ELISA were confirmed to have excellent validity and diagnostic utility in blood donors, which is important for HIV control and blood safety policies.
Keywords : blood bank; enzyme-linked immunosorbent assay (ELISA); meta-analysis; diagnostic validity; human immunodeficiency virus (HIV).